DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Vermeire S, Schreiber S, Petryka R. et al
Clinical remission in patients with moderate-to-severe Crohn’s disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
Lancet 2017;
389: 266-275
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.